BELBUCA

Peak

buprenorphine hydrochloride

NDABUCCALFILM

Approved

Oct 2015

Lifecycle

Peak

Competitive Pressure

0/100

Mechanism of Action

mu-opioid receptor and an antagonist at the kappa-opioid receptor.

Indications (3)

severe persistent pain including immediate-release opioids

Loss of Exclusivity

LOE Date

Dec 21, 2032

82 months away

Patent Expiry

Dec 21, 2032

Patent Records (3)

Patent #	Expiry	Type	Use Code
8147866	Jul 23, 2027	Product	U-1769
9655843	Jul 23, 2027	Product	U-1556
9901539	Dec 21, 2032		U-1556

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers